Scott Robert Peterson serves as Executive at Cascadian Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Scott Robert Peterson has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 9, 2018 involved transacting 3,639 shares valued at $0.
Scott Robert Peterson currently holds 3,639 shares of Cascadian Therapeutics, Inc. (CASC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Robert Peterson has been a net neutral trader of CASC stock. They have purchased $0 and sold $0 worth of shares.
Scott Robert Peterson's most recent insider trade was on Mar 9, 2018, when they sold 3,639 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.92 |
| Discretionary |
| Jan 11, 2018 | CASC | $0 | Option Exercise | 2,825 | $N/A | Discretionary |